Prostate Cancer News Jump To Jump To 2024 2023 What's the latest news in prostate cancer? Explore this page for the latest prostate cancer insights, research breakthroughs, trending discussions, news coverage, and thought-provoking editorials. Stay informed and engaged with our comprehensive updates. 2024 American Cancer Society Reports 2024 Facts & Figures The American Cancer Society's Facts & Figures report provides vital insights for 2024, where the U.S. faces a surge in cancer cases, urging attention to early detection, especially in prostate cancer. Disparities persist, underscoring the need for equity. Prostate Cancer Diagnosis of Secretary Lloyd Austin Draws Attention to Disease 2023 Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer. Educating Patients and Caregivers About Prostate Cancer Dr. Alicia Morgans emphasizes the importance of educating prostate cancer patients and caregivers through trusted resources, like the Prostate Cancer Foundation and ZERO Prostate Cancer, and encourages open communication with medical teams, addressing topics such as cancer curability, treatment options, sexual health, mental health, and the need for support in the context of prostate cancer care. Listen: New Bill Aims to Reduce Prostate Cancer Deaths in D.C. A new bill in D.C. aims to reduce high prostate cancer fatality rates, especially among black men, by mandating annual insurance coverage for prostate cancer screenings, addressing disparities in access to testing and improving early diagnosis for better survival rates. When Screening for Prostate Cancer Comes Too Late Prostate cancer screening methods are under review for better targeting high-risk groups and addressing stagnant death rates and late-stage diagnoses. U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA® Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval Some Men with Prostate Cancer Can Avoid, Delay Harsh Treatments, Study Finds More men with prostate cancer could afford to delay their treatment, a decades-long study has found, suggesting that active monitoring by health-care professionals is an equally valid — and less harsh — option. PRESTO Trial Aims to Help Guide Treatment for Patients with Rising PSA After Surgery Clinical Trials of New Therapies for Advanced Prostate Cancer More Stories and News Check out our official news and statements, blog stories, and see who's talking about us! ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! Blogs Blogs Our blogs feature commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events. Press & Media Inquiries Press & Media Inquiries Explore our newsroom for press releases and official statements about ZERO's latest updates, achievements, and partnerships.